$31.00
Movinaza-10 is used: with diseases of the musculoskeletal system, surgical diseases (ligament ruptures, sprains, fractures, dislocations, edema); with diseases of the ENT organs (in order to facilitate the discharge of the secret of the paranasal sinuses); with diseases of the respiratory system (in order to reduce the viscosity of sputum, to facilitate its discharge from the respiratory tract); with skin diseases (with acute inflammatory dermatoses); with diseases of the mammary glands, female genital organs (hematomas, stagnation in the mammary glands).
Description
Movinaza-10 composition
Active ingredient: serratiopeptidase (10 mg / 20 thousand units).
Excipients: diethyl phthalate, povidone, microcrystalline cellulose, magnesium stearate, sodium starch, talc, croscarmellose sodium, titanium dioxide, eudragit L100, hypromellose, iron oxide red E172, castor oil, polyethylene glycol 6000.
Release form
Available in tablet form.
Pharmacological properties
It is an enzymatic agent used for disorders of the musculoskeletal system. It is a proteolytic enzyme that has been isolated from the intestinal bacterium Serratia E15 (non-pathogenic). It has fibrinolytic, anti-edematous, anti-inflammatory activity. Relieves pain, reduces inflammation due to the ability to block the release of pain amines from tissues. Directly reduces the expansion of capillaries, controls their permeability by hydrolysis of serotonin, bradykinin, histamine. Also blocks plasmin inhibitors, contributing to its fibrinolytic activity. Improves the rheological properties of sputum, promotes its discharge. In the focus of chronic inflammation, it helps to reduce the level of pro-inflammatory mediators, pain, hydrolyzes fibrin, preventing the occurrence of adhesions, and improves microcirculation.
Indications
Movinaza-10 is used:
- with diseases of the musculoskeletal system, surgical diseases (ligament ruptures, sprains, fractures, dislocations, edema);
- with diseases of the ENT organs (in order to facilitate the discharge of the secret of the paranasal sinuses);
- with diseases of the respiratory system (in order to reduce the viscosity of sputum, to facilitate its discharge from the respiratory tract);
- with skin diseases (with acute inflammatory dermatoses);
- with diseases of the mammary glands, female genital organs (hematomas, stagnation in the mammary glands).
Contraindications:
- with intolerance to the components of the drug;
- in violation of blood clotting.
Children
It is not used in pediatric practice due to the lack of clinical data.
Application during pregnancy and lactation
The use of this drug is not recommended during pregnancy, lactation due to the lack of clinical data.
Method of administration and dosage
Movinaza-10 is administered orally (after meals). The tablet should be swallowed without chewing with one glass of water.
The standard starting dose is one tablet 1-3 times a day.
The maximum dose that can be taken per day is 30 mg.
The dosage, the duration of the course of therapy depend on the nature, dynamics of the pathological process, therefore, it is determined in each case individually by the doctor.
Overdose
Symptoms: nausea, anorexia, vomiting, epigastric discomfort, bleeding, streaks of blood in the sputum.
Treatment: symptomatic therapy. With an increase in blood pressure, tachycardia, beta-blockers may be prescribed.
Side effects:
- Respiratory disorders: sputum streaked with blood, epistaxis, acute eosinophilic pneumonia.
- Immune disorders: allergic reactions (rash, itching, urticaria, redness of the face and skin, angioedema, bronchospasm, shortness of breath), anaphylactic shock.
Storage conditions and periods
Store Movinaza-10 for no more than three years at temperatures up to + 25 ° C.
It is forbidden to use after the expiry date indicated on the package.
Parents are obliged to ensure the safety of children, excluding the possibility of their access to medicine.
Recent Reviews